Use for nutritional assessment of vitamin A (retinol and retinyl palmitate) in serum or plasma.
Quantitative High Performance Liquid Chromatography (HPLC)
New York DOH Approval Status
Patient should fast for 12 hours and abstain from alcohol for 24 hours prior to collection.
Green (sodium or lithium heparin), plasma separator tube, or serum separator tube. Also acceptable: Lavender (EDTA) or pink (K2EDTA).
Separate serum or plasma within 1 hour of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube immediately. (Min: 0.2 mL) Avoid hemolysis.
Whole blood or body fluids other than serum or plasma.
After separation from cells: Ambient: Unacceptable; Refrigerated: 1 month; Frozen: 1 year
|Vitamin A (Retinol)||
|Vitamin A (Retinyl Palmitate)||0-150 years: 0-0.10 mg/L|
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Serum retinol is typically maintained until hepatic stores are almost depleted. Values greater than 0.30 mg/L represent adequate liver stores, whereas values less than 0.10 mg/L indicate deficiency. Samples that come in contact with plastic tubing or have been exposed to excessive light may show low results.
Vitamin A toxicity occurs when retinol concentration exceeds the capacity of retinol binding protein (RBP). Individuals with compromised renal function can retain RBP and may, therefore, have moderate retinol elevations. Drugs which interfere with vitamin A analysis include probucol (Lorelco).
This assay does not measure other vitamin A metabolites such as retinaldehyde and retinoic acid.
|Component Test Code*||Component Chart Name||LOINC|
|0080375||Vitamin A (Retinol)||2923-1|
|0080523||Vitamin A, Ser/Pla - Interpretation||48767-8|
|0080524||Vitamin A (Retinyl Palmitate)||38496-6|
- A Vitamin
- Retinyl palmitate